What Pfizer can learn in Tennessee when it comes to vaccine rollout
Tennessee’s diversity, size and urban-to-rural ratio are thought to be assets for drug-maker hoping to iron out vaccine distribution wrinkles. (Jim Weber/Daily Memphian)
Tennessee’s diversity, size and urban-to-rural ratio are thought to be assets for drug-maker hoping to iron out vaccine distribution wrinkles.
Topics
Clint Hermes Stacey Schultz-Cherry vaccine PfizerJane Roberts
Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers business news and features for The Daily Memphian.
Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here.